Insider Stock Trading History of Powell Michael


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Powell Michael since year 2005. The trader's CIK number is 1202793. At the time of this reporting, Powell Michael is the of Tranzyme Inc . (stock ticker symbol TZYM). See this page for all insider trading activities at Tranzyme Inc .

Note that in the past POWELL MICHAEL also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Powell Michael since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-09-12 OCRX Tranzyme Inc Sale 6,512 2.29 14,925
2016-10-20 MRNS Marinus Pharmaceuticals Inc Sale 750,683 1.39 1,042,698
2016-07-11 OCRX Tranzyme Inc Option Ex 11,969 1.26 15,080
2015-10-13 ACRS Aclaris Therapeutics, Inc. Buy 409,090 11.00 4,499,990
2015-10-06 MIRN Mirna Therapeutics, Inc. Buy 857,142 7.00 5,999,994
2014-08-05 MRNS Marinus Pharmaceuticals Inc Buy 750,683 8.00 6,005,464
2014-07-09 AERI Aerie Pharmaceuticals Inc Sale 1,000,000 24.00 24,001,000
2014-07-10 AERI Aerie Pharmaceuticals Inc Sale 8,022 25.81 207,031
2014-06-04 HPTX Hyperion Therapeutics Inc Sale 417,747 27.70 11,571,591
2014-03-26 VSAR Versartis, Inc. Buy 60,000 21.00 1,260,000
2013-07-15 OCRX Tranzyme Inc Buy 391,166 6.03 2,357,166
2012-03-26 TSRX Trius Therapeutics Inc Option Ex 9,302 1.29 11,999
2012-01-18 TSRX Trius Therapeutics Inc Sale 4,300 5.56 23,895
2012-01-19 TSRX Trius Therapeutics Inc Sale 2,600 5.64 14,661
2012-01-13 TSRX Trius Therapeutics Inc Sale 8,522 5.46 46,572
2012-01-17 TSRX Trius Therapeutics Inc Sale 16,100 5.43 87,423
2010-12-21 OREX Orexigen Therapeutics, Inc. Sale 375,339 8.38 3,144,965
2010-12-22 OREX Orexigen Therapeutics, Inc. Sale 250,721 8.30 2,081,736
2010-12-23 OREX Orexigen Therapeutics, Inc. Sale 198,940 8.09 1,609,424
2010-12-17 OREX Orexigen Therapeutics, Inc. Sale 131,254 8.76 1,149,522
2010-12-20 OREX Orexigen Therapeutics, Inc. Sale 325,000 8.51 2,764,125
2010-08-06 TSRX Trius Therapeutics Inc Buy 830,000 5.00 4,150,000
2010-03-19 OREX Orexigen Therapeutics, Inc. Sale 210,000 6.00 1,260,000
2010-03-17 OREX Orexigen Therapeutics, Inc. Sale 152,000 6.29 955,471
2010-03-18 OREX Orexigen Therapeutics, Inc. Sale 338,000 6.15 2,077,686
2009-09-10 OREX Orexigen Therapeutics, Inc. Sale 400,000 9.18 3,670,000
2009-08-12 OREX Orexigen Therapeutics, Inc. Sale 400,000 8.00 3,200,000
2008-08-29 OREX Orexigen Therapeutics, Inc. Sale 700 12.09 8,460
2008-08-27 OREX Orexigen Therapeutics, Inc. Sale 20,000 12.05 241,040
2008-08-28 OREX Orexigen Therapeutics, Inc. Sale 10,800 12.04 130,086
2008-08-21 OREX Orexigen Therapeutics, Inc. Sale 5,300 12.00 63,600
2008-08-25 OREX Orexigen Therapeutics, Inc. Sale 4,800 12.00 57,609
2007-12-18 ANSV Corgentech Inc Buy 3,703,704 4.05 15,000,001
2006-08-15 ANSV Corgentech Inc Buy 1 6.86 6
2006-03-16 THLD Threshold Pharmaceuticals Inc Sale 2,562,000 14.25 36,508,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Powell Michael ( of Tranzyme Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.